A review of Creutzfeldt-Jakob disease and other prion diseases;Revisión de la enfermedad del Creutzfeldt-Jakob y otras enfermedades priónicas

Revista de Neurologia

Volumn 31, Issue 12, 2000, Pages 1171-1179

  Zivkovic, S ^a   Boada, M ^a   Lopez O ^a  

^a Fundació ACE   (Spain)

Author keywords

Creutzfeldt Jakob disease; Dementia; Genetics; Heidenhain variant; Posterior cortical atrophy; Prion diseases

Indexed keywords

GLYCOPROTEIN;

AKINETIC MUTISM; CEREBRAL BLINDNESS; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE COURSE; ELECTROENCEPHALOGRAM; EXTRAPYRAMIDAL SYMPTOM; MEDICAL INFORMATION; MORBIDITY; MYOCLONUS; NEUROMUSCULAR SYNAPSE; NEUROPATHOLOGY; NEUROTOXICITY; PALATINE TONSIL; PATHOPHYSIOLOGY; PRION DISEASE; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DEGRADATION; REVIEW;

EID: 0034480286     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3112.2000423     Document Type: Review

References (127)

1. Human prion diseases: Etiology and clinical features
2. Medical progress: ECJ and related transmissible spongiform encephalopathies
3. Human prion disease
4. Creutzfeldt-Jakob disease: A clinical analysis of a consecutive series of 230 neuropathologically verified cases
5. Deadly conformations: Protein misfolding in prion disease
6. The susceptibility of sheep, goats and mice to two types of goat scrapie agent
7. Human spongiform encephalopathy: The NIH series of 300 cases of experimentally transmitted disease
8. Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering
9. The epidemiology of Creutzfeldt-Jakob disease: Conclusion of the 15-year investigation in France and review of the world literature
10. Creutzfeldt-Jakob disease in a husband and wife
11. Degenerative diseases of the central nervous system in New Guinea: The endemic occurrence of 'kuru' in the native population
12. Pathology of kuru
13. Unconventional viruses and the origin of kuru
14. Transmission of scrapie in hamsters
15. Inherited susceptibility, ovine brain consumption and Creutzfeldt-Jakob disease (ECJ)
16. Creutzfeldt Jakob disease: Possible transmission to humans by consumptions of wild animal brains
17. Creutzfeldt Jakob disease and eating squirrel brains
18. Inherited susceptibility, ovine brain consumption and Creutzfeldt-Jakob disease
19. Case control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995
20. Creutzfeldt-Jakob disease in Western India
21. Creutzfeldt-Jakob disease in a lifelong vegetarian
22. Molecular analysis of prion strain variation and the aetiology of 'new variant' ECJ
23. Sporadic Creutzfeldt-Jakob disease in an 18-year old in UK
24. Sporadic Creutzfeldt- Jakob disease in a 16-year old in UK
25. BSE: A decade on: Part I
26. Epidemiology of Creutzfeldt-Jakob disease
27. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: Analysis of epidemiologic surveillance data for 1970-1996
28. New variant of Creutzfeldt-Jakob disease in a 26-year old French man
29. Creutzfeldt-Jakob disease in Europe
30. Commentary: Age related exposure of patients to the agent of BSE should not be downplayed
31. High-dose exposure to systemic phosmet insecticide modifies the phosphatidylinositol anchor on the prion protein: The origins of new variant transmissible spongiform encephalopathies?
32. Retrospective neuropathological review of prion disease in UK hemophilic patients
33. Creutzfeldt-Jakob disease (ECJ) after blood product transfusion from a donor with ECJ
34. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
35. Canada lifts the ban on blood donors with Creutzfeldt-Jakob disease
36. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: A case control study
37. Creutzfeldt-Jakob disease in physician: A review of the disorder in health care workers
38. Tissue handling in suspected Creutzfeldt-Jakob diseases (CJD) and other human spongiform encephalopathies (prion diseases)
39. Creutzfeldt-Jakob disease
40. La maladie de Creutzfeldt-Jakob en France continental, Étude retrospective de 1968-1977
41. Diagnosis of Creutzfeldt-Jakob disease. Effect of clinical criteria on incidence estimate
42. The ataxic form of Creutzfeldt-Jakob disease
43. Clinical and diagnostic findings in a patient with Creutzfeldt-Jakob disease (type Heidenhain)
44. The Heidenhain variant of Creutzfeldt-Jakob disease
45. Panencephalopathic type of Creutzfeldt-Jakob disease: Primary involvement of the cerebral white matter
46. Creutzfeldt-Jakob disease in Japan
47. Panencephalopathic type of Creutzfeldt-Jakob disease with primary extensive involvement of white matter
48. Syndromes of amyotrophic lateral sclerosis and dementia: Relation to transmissible Creutzfeldt-Jakob disease
49. Amyotrophy in prion diseases
50. Clinical and neuropathological criteria for frontotemporal dementia
51. Diagnosis of dementia: Clinicopathologic correlations
52. Dificultades en el diagnóstico diferencial de la enfermedad de Creutzfeldt-Jakob de curso prolongado
53. Creutzfeldt-Jakob disease of long duration: Clinicopathological characteristics, transmissibility and differential diagnosis
54. A new variant of Creutzfeldt-Jakob disease in the United Kingdom
55. New variant of Creutzfeldt-Jakob disease: Neurological features and diagnostic tests
56. New variant of Creutzfeldt-Jakob disease: Psychiatric features
57. Friendly fire in medicine: Hormones, homografts and Creutzfeldt-Jakob disease
58. Latrogenic Creutzfeldt-Jakob disease: An example of interplay between ancient genes and modern medicine
59. Creutzfeldt-Jakob disease after liver transplantation
60. Creutzfeldt-Jacob disease with features of obsessive-compulsive disorder and anorexia nervosa: The role of cortical-subcortical systems
61. Creutzfeldt-Jakob disease appearing as paranoid psychosis
62. How to improve clinical diagnosis of Creutzfeldt-Jakob disease
63. Early evolution of incidence of electroencephalographic abnormalities in Creutzfeldt-Jakob disease
64. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease
65. Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease
66. Fatal familial insomnia: Clinical and pathologic study of five new cases
67. Phenotypic variability in fatal insomnia (D178N-129M) genotype
68. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies
69. Cerebrospinal fluid test for new variant Creutzfeldt-Jakob disease
70. Utilidad diagnóstica de la determinación de la proteína 14-3-3 en el líquido cefalorraquídeo en la enfermedad de Creutzfeldt-Jakob
71. 14-3-3 Protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
72. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease
73. Decreased ß-Amyloid (1-42) in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
74. Elevated levels of Tau protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
75. MR imaging of Creutzfeldt-Jakob disease
76. MRI in sporadic Creutzfeldt-Jakob disease: Correlation with clinical and neuropathological data
77. Diffusion weighted magnetic resonance imaging in Creutzfeldt-Jakob disease
78. Diffusion weighted MRI in sporadic Creutzfeldt-Jakob disease
79. Diffusion weighted magnetic resonance imaging in probable Creutzfeldt-Jakob disease: A clinical-anatomic correlation
80. [18F]FDG PET in familial insomnia: The functional effects of thalamic lesions
81. Brain SPECT imaging with Tc-99HMPAO in Creutzfeldt-Jakob disease
82. Positron emission tomography and histopathology in Creutzfeldt-Jakob disease
83. Regional cerebral glucose metabolism in autopsy confirmed Creutzfeldt-Jakob disease
84. Creutzfeldt-Jakob disease (spongiform encephalopathy): Transmission to the chimpanzee
85. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease
86. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy
87. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
88. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy
89. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (ECJ) and other human spongiform encephalopathies (prion diseases)
90. Genetic and infectious prion diseases
91. Scrapie agent contains a hydrophobic protein
92. Purification and structural studies of a major scrapie prion protein
93. A 54-kDa normal cellular protein may be the precursor of the scrapie agent protease-resistant protein
94. Presence of prion proteins in peripheral tissues of Libyan Jews with Creutzfeldt-Jakob disease
95. Prion diseases and neurodegeneration
96. Prion protein is necessary for normal synaptic function
97. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease
98. Localization of a human gene homologous to the PrP gene on the p arm of chromosome 20, and detection of PrP-related antigens in normal human brain
99. Familial Creutzfeldt-Jakob disease in Chile is associated with the codon 200 mutation of the PRP amyloid precursor gene on chromosome 20
100. Molecular genetics of prion diseases in France
101. Polymorphism of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease
102. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: A systematic analysis of predisposing mutations and allelic variation in the PRNP gene
103. Transmissions to mice indicate that 'new variant' ECJ is caused by the BSE agent
104. The same prion strain causes vECJ and BSE
105. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin
106. A mutation in the priori protein gene in Creutzfeldt-Jakob disease in Jewish patients of Libyan, Greek, and Tunisian origin
107. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia
108. Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles
109. Novel twelve-generation kindred of fatal familial insomnia from Germany representing the entire spectrum of disease expression
110. Regional distribution of protease resistant prion protein in familial insomnia
111. Early pathologic and biochemical changes in Creutzfeldt-Jakob disease: Study of brain biopsies
112. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease
113. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
114. Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different PRNPSc types in the same brain
115. Normal development and behavior of mice lacking the neuronal cell-surface PRNP protein
116. Degeneration of skeletal muscle, peripheral nerves, and central nervous system in transgenic mice overexpressing wild-type prion proteins
117. Rescue of neurophysiological phenotype seen in PRP-null mice by transgene encoding human prion protein
118. No propagation of prions in mice devoid of PRNP
119. Cell-free formation of protease-resistant prion
120. Prion strains
121. Dapsone to delay symptoms in Creutzfeldt-Jakob disease
122. The natural incubation period of kuru and the episodes of transmission in three clusters of patients
123. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei
124. World Health Organization Consultation on Public Health Issues Related to Bovine Spongiform Encephalopathy and the Emergence of a New Variant of Creutzfeldt-Jakob Disease
125. Risk of transmission of bovine spongiform encephalopathy to humans in the United States. Report of the Council on Scientific affairs